about
International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease statesBombesin-related peptides and their receptors: recent advances in their role in physiology and disease statesHuman gastrin-releasing peptide receptor gene regulation requires transcription factor binding at two distinct CRE sitesReceptor binding peptides for target-selective delivery of nanoparticles encapsulated drugsInsights into bombesin receptors and ligands: Highlighting recent advancesGastrin-releasing peptide signaling plays a limited and subtle role in amygdala physiology and aversive memory.Isolation, identification and biological activity of gastrin-releasing peptide 1-46 (oGRP 1-46), the primary GRP gene-derived peptide product of the pregnant ovine endometrium.Molecular imaging of metastatic potential.Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.Facilitation of the inhibitory transmission by gastrin-releasing peptide in the anterior cingulate cortex.Magneto-Fluorescent Carbon Nanotube-Mediated siRNA for Gastrin-Releasing Peptide Receptor Silencing in Neuroblastoma.Hypoxia regulates the expression of the neuromedin B receptor through a mechanism dependent on hypoxia-inducible factor-1αGastrin-releasing peptide receptor in breast cancer mediates cellular migration and interleukin-8 expression.Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersGRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRIThe majority of dorsal spinal cord gastrin releasing peptide is synthesized locally whereas neuromedin B is highly expressed in pain- and itch-sensing somatosensory neuronsShrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonistGastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma.Protein kinase C regulates bombesin-induced rapid VEGF secretion in neuroblastoma cellsTargeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.Autophagy mediates paracrine regulation of vascular endothelial cellsBiologically active, non membrane-anchored precursors: an overview.Specific antibodies elicited by a novel DNA vaccine targeting gastrin-releasing peptide inhibit murine melanoma growth in vivo.Bombesin induces angiogenesis and neuroblastoma growth.Gastrin-releasing peptide (GRP) in the ovine uterus: regulation by interferon tau and progesteroneMidbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson's Disease.Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cellsActivation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesGastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.Bombesin enhances TGF-beta growth inhibitory effect through apoptosis induction in intestinal epithelial cells.ProCA1.GRPR: a new imaging agent in cancer detection.Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells.Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.Significance of gastrin-releasing peptide in ovarian cancer ES2 cellsTargeting the gastrin-releasing peptide receptor pathway to treat cognitive dysfunctionassociated with Alzheimer's Disease.Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.
P2860
Q24643524-C5A6DF45-C1FA-4665-B511-84066D005667Q24645097-04ADFB81-4CEE-478B-AD58-8B233E2C3F06Q24649884-9532E76F-965B-4460-9198-86C1C9D427AFQ26849241-0FB83646-71A3-4A59-88E4-C2399ACCD24FQ28081153-6BEABA52-3F64-4282-982F-DC6B43803B71Q28730635-68CBD687-76D8-4912-99DE-4987DD1E1B18Q30925323-52482EE3-B851-4BF6-A1EF-5359F31DD1F6Q33917943-7B363F91-2B59-4406-895C-E3A75860C56BQ33918128-2E595945-1F26-480D-88AF-599D6AB45723Q34156922-30AE0EA6-4452-46DF-A39E-DE72A1E2515AQ35043610-F8E4799B-B8FC-4940-8B3E-6BA1EF8FBC48Q35070598-59BAA0C2-A710-4426-AD19-BFA9EAE0BCB3Q36067344-C45A05B7-A423-40D8-BD9C-355D9C4FAB6BQ36116233-3545F65E-115C-4DE3-A9B5-1677EE9177EAQ36291569-3D87C059-5005-4081-A033-EB45A7F3D445Q36391729-A87B413A-52B1-4AB1-B9F6-B626B6CA1024Q36617058-E5D82979-FE8C-414A-BB62-3BE0F8304770Q36861785-69A7E58A-392D-42FA-B4D4-9353AF56961EQ36890436-77D0F591-9D1D-4380-A937-B388A1091CA7Q36890860-C9E39E96-6463-431D-BBC9-2A2FA025F369Q36892227-3D75A3FA-52BF-435E-B98B-FA982D063E98Q37126747-733FA578-0FAC-41D5-A17C-14FD0D43EEF7Q37256078-1554AB7A-DA64-45E3-A0C4-63137B43CA11Q37259715-316598C9-54E3-4A84-B8E9-479A1877F9B3Q37273020-0506C600-6E93-49EB-84F6-5A980584479DQ37352812-95E09239-5B2C-4C60-8A1C-392EFCC23AF0Q37398035-8E389F33-2C30-4A08-8D6F-CC6E45B26255Q37579308-5F8BD656-7E68-4CC0-A650-FF9BDC1AC33CQ37641064-B1442799-D333-4449-9E0B-428DBDAF4A9FQ37641718-71200E8C-6460-4119-9584-1C0631ED9486Q38216009-7ADBB16B-FFEE-47DC-A7EC-BB477A79F386Q38789171-2CEB7A0E-ABC9-4C18-95BC-F1D62FD69EE1Q39820926-4A250733-1A3E-49EC-8FB9-8B6A124F19A8Q40983703-10AC6F62-4292-42AC-93D8-83D65E9EBB94Q40994215-8311A9F4-BC7A-4370-BF65-302D173530F1Q41323772-21E4C5FC-CB79-46D8-A2B7-AD5F7DA68D0FQ41550190-D941EF4F-80F0-46CD-9165-369492624667Q47107287-D31D1814-8863-4C3D-B4E9-BBE2CD4FD1E9Q47159086-47980008-9446-488E-A238-3B3442B69492Q48098858-1051A3BC-5E09-4DC1-BA6F-D06C5BA6D8C3
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Gastrin-releasing peptide and cancer.
@ast
Gastrin-releasing peptide and cancer.
@en
type
label
Gastrin-releasing peptide and cancer.
@ast
Gastrin-releasing peptide and cancer.
@en
prefLabel
Gastrin-releasing peptide and cancer.
@ast
Gastrin-releasing peptide and cancer.
@en
P2093
P1476
Gastrin-releasing peptide and cancer.
@en
P2093
Arthur Shulkes
Graham S Baldwin
Oneel Patel
P356
10.1016/J.BBCAN.2006.01.003
P407
P577
2006-01-31T00:00:00Z